Berger, J. R., and Sheremata, W. A. Persistent neurological deficit precipitated by hot bath test for multiple sclerosis. J.A.M.A. 249:1751, 1983.
Chiappa, K. H. Pattern shift visual, brainstem auditory, and short-latency somatosensory-evoked potentials in multiple sclerosis. Neurology (Minneapolis) 30:110, 1980.
Clark, V. A., et al. Factors associated with a malignant or benign course of multiple sclerosis. J.A.M.A. 248:856, 1982.
Koopmans, R. A., et al. Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features. Ann. Neurol. 25:74, 1989.
Miller, D. H., Morrissey, S. B., and McDonald, W. I. The prognostic significance of brain MRI at presentation with a single episode of suspected demyelination: A five year follow-up study. Neurology 42:427, 1992.
Nelson, L. M., et al. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. J.A.M.A. 259:3441, 1988.
Paty, D. W., et al. MRI in diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180, 1988.
Percy, A. K., et al. Multiple sclerosis in Rochester, Minn.: A 60-year appraisal. Arch. Neurol. 25:105, 1971.
Rudick, R. A., et al. Multiple sclerosis: The problem of incorrect diagnosis. Arch. Neurol. 43:578, 1986.
Spencer, W. Suspicion of multiple sclerosis: To tell or not to tell? Arch. Neurol. 45:441, 1988.>
Troiano, R., et al. Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis. Ann. Neurol. 15:257, 1984.
Willoughby, E. W. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients. Ann. Neurol. 25:43, 1989.
Wolinsky, J. S. Multiple sclerosis. Curr. Neurol. 13:167, 1993.
Chrouso, G. A., et al. Side effects of glucocorticoid treatment: Experience of the optic neuritis treatment trial. J.A.M.A. 269:2110, 1993.
Compston, A. Methylprednisolone and multiple sclerosis. Arch. Neurol. 45:670, 1988.
Duquette, P., et al. Interferon beta-1B is effective in relapsing remitting multiple sclerosis: Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655, 1993.
Hauser, S. L., et al. Intensive immunosuppression in progressive multiple sclerosis: A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N. Engl. J. Med. 308:173, 1983.
Kappos, L., et al. Cyclosporine versus azathioprine in the longterm treatment of multiple sclerosis: Results of The German Multicenter Study. Ann. Neurol. 23:56, 1988.
Killian, J. M., et al. Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis. Arch. Neurol. 45:27, 1988.
Menken, M. Consensus and controversy in neurologic practice: The case of steroid treatment in multiple sclerosis. Arch. Neurol. 46:322, 1989.
Weiner, H. L., and Hafler, P. A. Immunotherapy of multiple sclerosis. Ann. Neurol. 23:211, 1988.